Avoro Capital Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$9.2M Buy
2017
Q3
$7.45M Hold
2017
Q2
$6.77M Hold
2017
Q1
$7.54M Buy
2016
Q4
$3.97M Sell
2016
Q3
$9.2M Sell
2016
Q2
$5.42M Buy
2016
Q1
$5.17M Sell
2015
Q4
$9.14M Sell
2015
Q3
$15.1M Sell
2015
Q2
$21M Buy
2015
Q1
$7.32M Buy
2014
Q4
$5.68M Buy